0 items

in your cart

Prescription Drug Search

Strengths available for Gleevec:

Gleevec 100mg
Gleevec 400mg

Search for a drug:


Browse Alphabetically:

A · B · C · D · E · F · G · H · I · J · K · L · M · N
O · P · Q · R · S · T · U · V · W · X · Y · Z · #

Information about ExpressMedsCanada.com

SSL Secured Website Certified Global Pharmacy Network Hacker Proof: Safe Shopping Experience 5th Anniversary 2002-2007

List of countries where we can ship Gleevec:

  • Albania
  • Antigua and Barbuda
  • Argentina
  • Armenia
  • Aruba
  • Bahrain
  • Belgium
  • Cayman Islands
  • China
  • Colombia
  • Cook Islands
  • Cuba
  • Dominican Republic
  • Ecuador
  • El Salvador
  • Estonia
  • France
  • Greenland
  • Guadeloupe
  • India
  • Iraq
  • Jamaica
  • Jordan
  • Lithuania
  • Monaco
  • Panama
  • Qatar
  • Serbia
  • Singapore
  • South Africa
  • Spain
  • Switzerland
  • Taiwan
  • Tunisia
  • United Arab Emirates
  • United Kingdom, UK
  • United States, US
  • Uruguay
  • Uzbekistan
  • Yemen
View All Countries

Latest news releases on Gleevec:

AB SCIENCE : Recruitment of the First Patient for the Phase 3 Study on Gleevec®-Resistant GIST, Comparing Masitinib with Sunitinib - 4-traders (press release)

AB Science SA (Euronext Paris - FR0010557264 - AB)(Paris:AB), a pharmaceutical company specialized in research, development and commercialization of protein kinase inhibitors (PKI), announces today the recruitment of the first patient in a phase 3 study ...

Biotechnology Stocks To Watch Ahead Of ASCO 2012: Part 3 - Seekingalpha.com

Long-term follow-up data on SPRYCEL (dasatinib) in patients with chronic-phase CML resistant or intolerant to Gleevec to be presented. The details of the abstracts and schedule can be found here. Bristol Myers Squibb has a market cap of $55.89 billion and ...

Fidelity Biosciences invests in Blueprint Medicines - Boston Globe

A Globe story then noted that Blueprint Medicine’s scientific cofounders, Dr. Nicholas Lydon and Dr. Brian Druker, had won the prestigious Lasker-DeBakey Clinical Medical Research Award in 2009 for their role in developing Gleevec, a kinase ...

Novartis: The Market Is Wrong About This Pharma Stock - Seekingalpha.com

Perhaps the biggest near-term hurdle for Novartis is a highly publicized battle to prevent Indian pharmaceutical firms from making a generic version of Gleevec, the company's patented $1.5-billion-a-year leukemia drug. Besides threatening a major revenue ...

Named professorship to honor cancer researcher Janet Rowley, MD - phys.org

"That was the frosting on the cake." Understanding the 9;22 translocation eventually led to the development of the drug imatinib (Gleevec), one of the most successful targeted cancer therapies to date. Gleevec blocks an abnormal growth ...

New cancer test at Norwalk Hospital could prove key - Amity Observer

Examples include Herceptin® for the treatment of breast cancer, Rituxan® for the treatment of lymphoma and Gleevec® for the treatment of CML (chronic myelogenous leukemia). “Those drugs have revolutionized cancer treatment,” Dr. Frank said.

Grant to fund use of kinase test in HER2-positive breast cancer - Bladen Journal

Tremendous efforts have been made to develop kinase inhibitors as cancer treatments, which have resulted in key drugs such as Herceptin®, Tykerb®, and Gleevec®. However, in spite of the effectiveness of this class of cancer drugs, most cancers ...

New Data from Bristol-Myers Squibb Oncology Portfolio to be Presented at 2012 American Society of Clinical Oncology (ASCO) Annual Meeting - PharmiWeb

Gleevec®* (imatinib mesylate) in the treatment of patients with newly diagnosed Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML) in chronic-phase. Long-term follow up data (6 years) from the Phase 3 study (-034) that evaluated the ...

Dundee University disease research to receive £14m investment - Courier

The drug Gleevec, which has transformed a previously fatal form of leukaemia into a manageable disease, is one example of a kinase-targeting drug which has been introduced to the market in recent years. Speaking for the pharmaceutical companies in the ...

Customer Service
1-866-799-3435 - Use Discount Code 7500 | Contact Form
Copyright © 2012 ExpressMedsCanada.com All rights reserved. Disclaimer | Privacy Policy
Accepted Credit Cards and Payment: VISA, MASTERCARD and eCHECK